<SEC-DOCUMENT>0001140361-24-017622.txt : 20240403
<SEC-HEADER>0001140361-24-017622.hdr.sgml : 20240403
<ACCEPTANCE-DATETIME>20240403163152
ACCESSION NUMBER:		0001140361-24-017622
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20240403
DATE AS OF CHANGE:		20240403

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Royalty Pharma plc
		CENTRAL INDEX KEY:			0001802768
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-39329
		FILM NUMBER:		24819293

	BUSINESS ADDRESS:	
		STREET 1:		110 EAST 59TH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		(212) 883-0200

	MAIL ADDRESS:	
		STREET 1:		110 EAST 59TH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MGG Strategic SICAF SIF S.A. - MGG Strategic
		CENTRAL INDEX KEY:			0001814889
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			N4
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144

	BUSINESS ADDRESS:	
		STREET 1:		18 AVENUE DE LA PORTE NEUVE
		CITY:			LUXEMBOURG
		STATE:			N4
		ZIP:			L-2227
		BUSINESS PHONE:		352 26200068

	MAIL ADDRESS:	
		STREET 1:		18 AVENUE DE LA PORTE NEUVE
		CITY:			LUXEMBOURG
		STATE:			N4
		ZIP:			L-2227

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Nogra Group SICAF SIF MGG Strategic
		DATE OF NAME CHANGE:	20200611
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>144</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001814889</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>



</filerInfo>
</headerData>
<formData>
<issuerInfo>
<issuerCik>0001802768</issuerCik>
<issuerName>Royalty Pharma plc</issuerName>
<secFileNumber>001-39329</secFileNumber>
<issuerAddress>
<com:street1>110 EAST 59TH STREET</com:street1>
<com:city>NEW YORK</com:city>
<com:stateOrCountry>NY</com:stateOrCountry>
<com:zipCode>10022</com:zipCode>
</issuerAddress>
<issuerContactPhone>(212) 883-0200</issuerContactPhone>
<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>MGG Strategic SICAF SIF S.A. - MGG Strategic</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
<relationshipsToIssuer>
<relationshipToIssuer>See Remarks</relationshipToIssuer>
</relationshipsToIssuer>
</issuerInfo>
<securitiesInformation>
<securitiesClassTitle>Class A Ordinary Shares</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>UBS Securities LLC|</name>
<address>
<com:street1>1285 Avenue of the Americas</com:street1>
<com:city>New York</com:city>
<com:stateOrCountry>NY</com:stateOrCountry>
<com:zipCode>10019</com:zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>1000000</noOfUnitsSold>
<aggregateMarketValue>30370000</aggregateMarketValue>
<noOfUnitsOutstanding>446691515</noOfUnitsOutstanding>
<approxSaleDate>04/03/2024</approxSaleDate>
<securitiesExchangeName>NASDAQ</securitiesExchangeName>
</securitiesInformation>
<securitiesToBeSold>
<securitiesClassTitle>Class A Ordinary Shares</securitiesClassTitle>
<acquiredDate>06/18/2020</acquiredDate>
<natureOfAcquisitionTransaction>Acquired upon exchange of limited partnership interests in RPI US Partners 2019, LP and RPI International Holdings 2019, LP</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>23390000</amountOfSecuritiesAcquired>
<paymentDate>06/18/2020</paymentDate>
<natureOfPayment>Exchange of securities</natureOfPayment>
</securitiesToBeSold>
<nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
<remarks>The selling stockholder and certain related parties are significant stockholders of the Issuer.  The selling stockholder is wholly-owned by a trust of which M. Germano Giuliani who serves on the Board of Directors of the Issuer, is the beneficiary. Trades are in accordance with a trading plan that complies with Rule 10b5-1 and expires on June 30, 2024. Approximate date of sale range: April 3, 2024- June 30, 2024.</remarks>
<noticeSignature>
<noticeDate>04/03/2024</noticeDate>
<planAdoptionDates>
<planAdoptionDate>03/30/2023</planAdoptionDate>
</planAdoptionDates>
<signature>MGG STRATEGIC SICAF SIF S.A. ??? MGG Strategic, By: /s/ Achille G. Severgnini, Title: Director</signature>
</noticeSignature>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
